Cellentia is a specialty bioassay CRO, offering bioassay development, validation, and sample testings, from research and development samples to clinical trial samples. We also offer consultation service for bioassay strategies that will be clinical phase appropriate and assistance in regulatory affairs filing. Our unique specialty is that we are the only CRO who offers patient-derived metastatic cancer organoids for oncology drug screening and longitudinal monitoring of acquired drug resistance during clinical trials.